

share
Balhimycin CAS NO 140932-79-2
Unit Price:
CAS No.:140932-79-2
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Balhimycin is a potent glycopeptide antibiotic belonging to the vancomycin family, identified by CAS NO 140932-79-2. It is a critical compound for research into novel antibacterial agents and mechanisms of action against resistant Gram-positive bacteria. This high-purity material is essential for pharmaceutical R&D, microbiology studies, and as a reference standard in analytical laboratories.
Application
- Antibacterial Research: Used as a key reference compound in studies investigating the structure-activity relationships of glycopeptide antibiotics.
- Mechanism of Action Studies: Employed to explore bacterial cell wall synthesis inhibition and the molecular basis for vancomycin resistance.
- Pharmaceutical Development: Serves as a lead compound or intermediate in the discovery and synthesis of new antibiotic derivatives.
- Microbiological Assays: Utilized as a standard in potency testing and the development of bioassays for antibiotic activity.
- Analytical Reference Standard: Provides a high-purity benchmark for HPLC, LC-MS, and other analytical methods in quality control laboratories.
Basic Information
| Product Name | Balhimycin |
| CAS No. | 140932-79-2 |
| Molecular Formula | C66H75Cl2N9O24 |
| Molecular Weight | 1445.2 g/mol |
| Synonyms | Balhimycin; Antibiotic A-40926 complex; A-40926; A40926; (3S,6R,7R,22R,23S,26S,36S,38aS)-44-[[2-O-(3-Amino-2,3,6-trideoxy-β-D-arabino-hexopyranosyl)-β-D-glucopyranosyl]oxy]-6-[(carbamoylmethyl)carbamoyl]-3-(2-chloro-3,5-dihydroxy-4-methylbenzoyl)-22,23-dihydroxy-7,36-dimethoxy-26-methyl-5,24,28,38,39-pentaoxo-11-thia-4,8,25,27,35-pentaazaoctacyclo[28.6.1.113,16.02,14.09,34.010,33.019,37.020,31]nonatriaconta-10,12,14(37),15,17,19(31),20,29(38),30,32-decaene-23-carboxylic acid |
| EINECS | Contact for details |
Quality Control
Our Balhimycin is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and microbiological assays for potency. A detailed Certificate of Analysis (COA) is provided with every shipment, ensuring traceability and compliance with research-grade standards.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at 2-8°C. This product is hygroscopic (moisture-sensitive) and should be handled under anhydrous conditions to maintain stability.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (HPLC) | Conforms to reference standard |
| Identification (MS) | Conforms to structure |
| Purity (HPLC) | ≥ 95.0% |
| Water Content (KF) | ≤ 5.0% |
| Potency (Microbiological Assay) | ≥ 900 µg/mg |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Tyrothricin CAS NO 1404-88-2


Polymyxin B Sulfate CAS NO 1405-20-5


Gramicidin CAS NO 1405-97-6


Gramicidin C CAS NO 113-73-5


Colistin CAS NO 1066-17-7


Vancomycin CAS NO 1404-90-6


Vancomycin Hydrochloride CAS NO 1404-93-9


Capastat Sulfate CAS NO 1405-37-4


Cinnamycin CAS NO 1405-39-6


Bacitracin CAS NO 1405-87-4


Subtilin CAS NO 1393-38-0


Bacitracin Zinc CAS NO 1405-89-6


Thiostrepton CAS NO 1393-48-2


Polymixin-B-Sulfate CAS NO 1406-11-7


Fusafungine CAS NO 1393-87-9


Polymyxin B, n-Sulfomethyl Deriv., Sodium Salt CAS NO 1407-09-6


Amphomycin CAS NO 1402-82-0


Diplococcin CAS NO 1403-45-8


Marcescin CAS NO 1403-94-7


Colistina [Inn-Spanish] CAS NO 1404-31-5
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






